Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Zealand Pharma A/S (ZLDPF)

Zealand Pharma A/S (ZLDPF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
64.8200 -1.2960 (-1.96%) 04/17/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 64.8200 unch (unch) 11:06 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
64.8200
Day High
66.0000
Open 64.8200
Previous Close 66.1160 66.1160
Volume 600 600
Avg Vol 1,320 1,320
Stochastic %K 28.05% 28.05%
Weighted Alpha -39.96 -39.96
5-Day Change +2.8700 (+4.63%) +2.8700 (+4.63%)
52-Week Range 57.9700 - 141.7420 57.9700 - 141.7420
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 4,603,776
  • Shares Outstanding, K 71,024
  • Annual Sales, $ 9,090 K
  • Annual Income, $ -156,430 K
  • EBIT $ -184 M
  • EBITDA $ -181 M
  • 60-Month Beta 0.81
  • Price/Sales 516.42
  • Price/Cash Flow N/A
  • Price/Book 3.76
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.36
  • Most Recent Earnings $-0.59 on 02/20/25
  • Next Earnings Date 05/15/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.77
  • Number of Estimates 2
  • High Estimate -0.57
  • Low Estimate -0.97
  • Prior Year -0.54
  • Growth Rate Est. (year over year) -42.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.9700 +11.82%
on 04/07/25
Period Open: 84.5000
83.5200 -22.39%
on 03/19/25
-19.6800 (-23.29%)
since 03/14/25
3-Month
57.9700 +11.82%
on 04/07/25
Period Open: 99.4700
110.0000 -41.07%
on 01/24/25
-34.6500 (-34.83%)
since 01/17/25
52-Week
57.9700 +11.82%
on 04/07/25
Period Open: 86.7500
141.7420 -54.27%
on 08/16/24
-21.9300 (-25.28%)
since 04/17/24

Most Recent Stories

More News
2 Weight Loss Stocks That Are Screaming Buys in December

With drugs like Novo Nordisk 's Wegovy becoming household names over the last couple of years, it's no surprise that there are quite a few opportunities to invest in the burgeoning market for weight-loss...

LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
Buy This Pharma Stock to Bet on the Next Blockbuster Weight-Loss Drug

A shocking study in The Lancet showed that nearly three-quarters of U.S. adults are overweight or obese. Chances are that by 2050, there will be 260 million overweight Americans. We already have GLP-1...

NVO : 58.08 (-7.63%)
LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom

The future of the weight loss market might not revolve around GLP-1 drugs.

BIOA : 3.87 (+3.20%)
LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
This GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its Money

Its GLP-1 medicines are just one reason why it could threaten Novo Nordisk.

NVO : 58.08 (-7.63%)
LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
This Rising Biotech Is a Fantastic Weight-Loss Stock to Buy Now

Its pipeline is one of the best among weight loss-focused biotechs right now.

LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
Better Weight Loss Drug Stock: Viking Therapeutics vs. Zealand Pharma

Both companies have a clear path to competing successfully in the market.

VKTX : 23.94 (+1.44%)
LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
3 Monster Stocks in the Making to Buy Right Now

They're small now, but these stocks could grow much larger.

VKTX : 23.94 (+1.44%)
CRSP : 37.77 (-0.03%)
NVO : 58.08 (-7.63%)
VRTX : 489.10 (+0.66%)
ZLDPF : 64.8200 (-1.96%)
Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio

Could Zealand Pharma be a better option for growth-oriented investors?

LLY : 839.96 (+14.30%)
ZLDPF : 64.8200 (-1.96%)
Invest in the GLP-1 Drug Market With This New ETF

The market for anti-obesity drugs is massive one, worth potentially $100 billion or more based on some ...

NVO : 58.08 (-7.63%)
OZEM : 22.77 (+3.52%)
LLY : 839.96 (+14.30%)
ALT : 4.55 (+3.41%)
ZLDPF : 64.8200 (-1.96%)
Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss Stock.

The risk is higher, but so is the upside when it comes to Zealand Pharma.

ZLDPF : 64.8200 (-1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. The company's pipeline includes ZP4207, single-dose rescue treatment for acute, severe hypoglycemia; ZP1848 for short bowel syndrome and ZP4207, multiple-dose version intended...

See More

Key Turning Points

3rd Resistance Point 66.7867
2nd Resistance Point 66.3933
1st Resistance Point 65.6067
Last Price 64.8200
1st Support Level 64.4267
2nd Support Level 64.0333
3rd Support Level 63.2467

See More

52-Week High 141.7420
Fibonacci 61.8% 109.7411
Fibonacci 50% 99.8560
Fibonacci 38.2% 89.9709
Last Price 64.8200
52-Week Low 57.9700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro